期刊
CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS
卷 10, 期 5, 页码 397-406出版社
SPRINGER
DOI: 10.1007/s11910-010-0132-4
关键词
Multiple sclerosis; Health-related quality of life; Measurement; Chronic illness; Profiles; Utility assessment; Generic measures; Disease-specific measures; Patient-reported outcomes; Clinical trials; Registries; Clinical care
Multiple sclerosis (MS) is a complex demyelinating disease with a relatively unpredictable course. It is well established that MS has a significant impact on health-related quality of life (HRQL) for individuals at all stages of the disease. It is argued that clinicians offer treatment to their patients for three reasons: 1) to increase longevity, 2) to prevent future morbidity, and 3) to make patients feel better. To assess how well they are accomplishing the third of these goals, clinicians have come to depend on the direct measurement of patients' HRQL. We review the many physical and emotional symptoms and other consequences of MS that negatively influence HRQL, how HRQL is measured, the unique information these measures provide compared with clinical parameters, the benefit of treatment interventions, and how to include HRQL assessment and data from other sources in clinical encounters and suggest measures to consider for clinical use.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据